Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
CBN and PHARMEXCIL Sign MoU to Promote and Regulate Pharmaceutical Exports

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

CBN and PHARMEXCIL Sign MoU to Promote and Regulate Pharmaceutical Exports

Analysed 25 Aug 2026·2 sources analysed·India·Business
CBN and PHARMEXCIL Sign MoU to Promote and Regulate Pharmaceutical ExportsPreviousNext

The Central Bureau of Narcotics (CBN) and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) signed a Memorandum of Understanding to promote legitimate pharmaceutical exports while preventing diversion of controlled substances. The agreement aims to facilitate international trade, streamline export procedures, and develop a voluntary code of conduct for the industry. India is recognized as a leading global supplier of pharmaceutical products, and the partnership supports regulatory oversight under the Narcotic Drugs and Psychotropic Substances Act to safeguard the supply chain.

Sentiment
64%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (64/100). Lens Score 52/100.

Outlets measured: news18, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 25 Aug 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (64/100)

Sentiment was consistent across outlets (52–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 24 Aug, 04:47 pm. Other outlets followed.

24 Aug, 04:47 pm2 sources · 17 h25 Aug, 09:45 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Key Factors to Consider When Choosing Life Insurance Plans
Next →
Purple Style Labs to Launch Rs 680 Crore IPO Starting August 31
news1824 Aug, 04:47 pm
Central narcotics bureau, PHARMEXCIL sign pact to promote pharma exports
  • 2
    news1825 Aug, 09:45 am
    CBN and Pharmexcil sign MoU to regulate controlled substances in Pharma exports
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Central Drugs Standard Control OrganisationMinistry of FinanceFinance MinistryMinistry of Commerce and IndustryDepartment of RevenueCustomsCentral Bureau of Narcotics
    Corporate
    Pharmaceuticals Export Promotion Council of India
    Enforcement
    Central Bureau of Narcotics

    Story context

    Category
    Business
    Location
    India
    Sources analysed
    2
    Last analysed
    25 Aug 2026
    Key entities
    Memorandum of understandingIndiaMedicationMinistry of Finance (India)NarcoticNew DelhiBiopharmaceuticalMedical deviceActive ingredientHalalPapaver somniferumPsychoactive drug